Tekla Healthcare Opportunities Fund Cash Position Weight
THQ Fund | USD 20.30 0.47 2.37% |
Tekla Healthcare Opportunities fundamentals help investors to digest information that contributes to Tekla Healthcare's financial success or failures. It also enables traders to predict the movement of Tekla Fund. The fundamental analysis module provides a way to measure Tekla Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tekla Healthcare fund.
Tekla |
Tekla Healthcare Opportunities Fund Cash Position Weight Analysis
Tekla Healthcare's Percentage of fund asset invested in cash equivalents or risk-free instruments. About 40% of all global funds carry cash on their balance sheet.
Funds or ETFs that have over 40% of their value invested in low-risk instruments or cash equivalents typically attract conservative investors.
Competition |
In accordance with the recently published financial statements, Tekla Healthcare Opportunities has 0.0% in Cash Position Weight. This indicator is about the same for the Financial Services average (which is currently at 0.0) family and about the same as Asset Management (which currently averages 0.0) category. This indicator is about the same for all United States funds average (which is currently at 0.0).
Did you try this?
Run Price Exposure Probability Now
Price Exposure ProbabilityAnalyze equity upside and downside potential for a given time horizon across multiple markets |
All Next | Launch Module |
Tekla Fundamentals
Shares Outstanding | 41.34 M | ||||
Shares Owned By Institutions | 19.54 % | ||||
Number Of Shares Shorted | 14.15 K | ||||
Price To Earning | 6.76 X | ||||
Short Ratio | 0.14 X | ||||
Earnings Per Share | 2.71 X | ||||
Beta | 0.9 | ||||
Market Capitalization | 951.66 M | ||||
Annual Yield | 0.01 % | ||||
Year To Date Return | 7.75 % | ||||
One Year Return | 14.65 % | ||||
Three Year Return | 2.65 % | ||||
Five Year Return | 7.91 % | ||||
Last Dividend Paid | 1.35 |
About Tekla Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tekla Healthcare Opportunities's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tekla Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tekla Healthcare Opportunities based on its fundamental data. In general, a quantitative approach, as applied to this fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Tekla Healthcare
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tekla Healthcare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tekla Healthcare will appreciate offsetting losses from the drop in the long position's value.Moving against Tekla Fund
0.52 | FTCAX | Templeton Strained Bond | PairCorr |
0.37 | PYARX | Payden Absolute Return | PairCorr |
0.37 | LTFOX | Lord Abbett Affiliated | PairCorr |
0.37 | GAB | Gabelli Equity Trust | PairCorr |
0.34 | PYAIX | Payden Absolute Return | PairCorr |
The ability to find closely correlated positions to Tekla Healthcare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tekla Healthcare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tekla Healthcare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tekla Healthcare Opportunities to buy it.
The correlation of Tekla Healthcare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tekla Healthcare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tekla Healthcare Opp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tekla Healthcare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Tekla Fund
Tekla Healthcare financial ratios help investors to determine whether Tekla Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tekla with respect to the benefits of owning Tekla Healthcare security.
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Stocks Directory Find actively traded stocks across global markets |